Deltort

[Deltort @Verodeltort]

A vous tous ! J'attire votre attention sur ce message que je relais de la part de ma soeur pharmacienne. Merci de prendre quelques minutes pour lire l'annonce en description de l'image, et faire marcher vos réseaux pour l'aider dans sa recherche. Réponse par message privé SVP.

[EuroIntervention @EuroInterventio]

🔉The new Impact Factor of EuroIntervention is 6.2.
This achievement places the journal once again in the top quartile among cardiovascular publications and solidifies our position as the second-ranked subspecialty journal in interventional cardiology. Thank you to all!

[Davide Capodanno @DFCapodanno]

In this new Journal column, the authors take different sides to debate the future of transcatheter mitral valve replacement and whether it will remain a niche therapy or evolve into another breakthrough technology in interventional cardiology. https://t.co/EPJkPSCrsb

[EuroIntervention @EuroInterventio]

🔉NEW ISSUE OUT 👉 An ESC/EAPCI consensus statement on renal denervation; a debate on the future of TMVR; a mini focus on interventional pharmacology; impact of non-fatal periprocedural major adverse events on ten-year mortality, and more. #EAPCI https://t.co/Y3KhsFkEG5

[AsiaIntervention @AsiaInterv]

"Novel treatment of atrial functional tricuspid regurgitation using transcatheter bicaval valve implantation (TricValve)" by Quah Wy Jin et al.
https://t.co/335dJsqvwT

[Davide Capodanno @DFCapodanno]

I'm glad to announce the new impact factor of EuroIntervention: 7.728.

[Deltort @Verodeltort]

@nicolasamabile @EuroInterventio @DFCapodanno @GGStefanini @dmylotte @robebyrne @NievesGonzalo1 @sbrugaletta @Ortega_Paz @Syllho Congratulations Dr Amabile and thank you for your ongoing commitment to the journal! @EuroInterventio

[EuroIntervention @EuroInterventio]

📢SAVE THE DATE 🗓️
New #EIJonAir coming on February, Friday 11 at 6:30 PM (Paris time).
@SPyxaras and @sbrugaletta will discuss the new EuroCTO consensus document describing current DLMC! https://t.co/JnPeZmxFdB
@CtoEuro

[EuroIntervention @EuroInterventio]

#EIJONAIR 7 https://t.co/dhizzabZHJ

[Nicole Karam, MD, PhD, FESC @nickaram]

Join us on Twitter this Tuesday, 5:00pm for the new #EijonAir discussing the 30-day outcomes of #Cardioband in symptomatic functional #tricuspid regurgitation (Triband study). Don’t forget to tag #EIJOnAir in your tweets!

[AsiaIntervention @AsiaInterv]

"The Cardiological Society of India [...], works towards the prevention of CVD and the reduction of cardiovascular mortality by raising awareness among its members, other healthcare professionals and the public." by Padhinhare P. Mohanan
https://t.co/oVPsYXcwoC

[AsiaIntervention @AsiaInterv]

"Consolidating APSIC: a professional and educational platform for the generation of young interventional cardiologists from the Asia-Pacific region" by @Dr_AshokSeth
https://t.co/aIwj4ZKiAL

[EuroIntervention @EuroInterventio]

This consensus document of the Euro-CTO Club describes the technical characteristics and use of commercially available dual lumen microcatheters. #EAPCI https://t.co/qv7VfnBppv

[EuroIntervention @EuroInterventio]

Congratulations @AsiaInterv @APSIC6 🙌!

[EuroIntervention @EuroInterventio]

"ViV TAVR has emerged as an acceptable option for reintervention
in patients with malfunctioning bioprosthetic valves (THV or SHV)." An editorial by Serruys P, et al. #EAPCI https://t.co/iNPVBH8D50

[AsiaIntervention @AsiaInterv]

We're at @csicon2021 the 73rd Annual Conference of Cardiological Society of India 🇮🇳 in Hyderabad, the City of Pearls!

Thank you 🙏🏽to everyone who stopped by to get their copy - we hope you enjoy this new issue of AsiaIntervention📰#cardiotwitter

[EuroIntervention @EuroInterventio]

EIJ ON AIR #4 https://t.co/9QxUGUyUQ7

[EuroIntervention @EuroInterventio]

Don't miss our next edition of #EIJOnAir! We invite you to join the discussion on the recent article: #OCT to guide #PCI of the left main coronary artery: the LEMON study 🍋 Send your questions now with the hashtag #EIJOnAir👉https://t.co/lvnrsnKcLq #CardioTwitter

[EuroIntervention @EuroInterventio]

If you are a PCR companion, you're still in time to benefit from this special #EuroPCR participants offer🎁: free one-year subscription to the print📰/online💻 edition!
👉https://t.co/uwfPZPxznm

[Davide Capodanno @DFCapodanno]

Short-term percutaneous ventricular assist devices differ in their haemodynamic effects, management, indications, insertion techniques, and monitoring requirements. A Joint expert consensus document from the #EAPCI and #ACVC, free online, ahead of print. https://t.co/Hu6Y5ob5vm